Volker Schulz

@portefeuillefun

no investment advice. The portfolio is the "mostly virtual" successor to the real portfolio. Also see !

Düsseldorf, Germany
Vrijeme pridruživanja: prosinac 2011.

Tweetovi

Blokirali ste korisnika/cu @portefeuillefun

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @portefeuillefun

  1. proslijedio/la je Tweet

    Gates Foundation announces $100 million for coronavirus response

    Poništi
  2. proslijedio/la je Tweet
    prije 5 sati
    Poništi
  3. proslijedio/la je Tweet

    Programs in Development for Disease

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    prije 5 sati
    Poništi
  5. proslijedio/la je Tweet
    prije 5 sati

    BREAKING: China death toll at least 560; as Hubei province reports 70 additional fatalities

    Poništi
  6. proslijedio/la je Tweet
    prije 5 sati
    Poništi
  7. proslijedio/la je Tweet
    prije 5 sati

    halt

    Poništi
  8. prije 5 sati
    Poništi
  9. proslijedio/la je Tweet
    prije 5 sati

    Bristol-Myers files to sell 17.03M shares of common stock

    Poništi
  10. proslijedio/la je Tweet

    China coronavirus: labs worldwide scramble to analyse live samples

    Poništi
  11. prije 5 sati

    +5% in extended trading.

    Poništi
  12. prije 5 sati
    Odgovor korisniku/ci

    Sold 0.5k at $45.63, now 16k shares.

    Poništi
  13. prije 5 sati
    Odgovor korisniku/ci

    Sold 0.5k at $45.40, now 16.5k shares.

    Poništi
  14. prije 5 sati
    Odgovor korisniku/ci

    Sold 1k at $45.00, now 17k shares.

    Poništi
  15. proslijedio/la je Tweet
    prije 5 sati

    - Near-Term Rimegepant Approval Would be Just the Start; Initiate at BUY, $62 PT - KarXT a Potential Breakthrough in Schizophrenia Treatment; Initiate at BUY, $120 PT - SAGE-217 Still Climbing Up the Mountain; Initiate at NEUTRAL, $69 PT

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    prije 5 sati

    MIZHOU initiating coverage on nine companies in the biopharmaceuticals sector with five BUY rated stocks , and ) and four NEUTRAL rated stocks (LLY, , ALKS and ), while also assuming coverage of with a BUY rating.

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    prije 5 sati

    Mizuho initiating in Biopharmaceuticals - Buy, $96 - Neutral, $148 - Buy, $42 - Neutral, $19 - Assume Buy, $20 - Neutral, $107 - Buy, $62 - Buy, $120 - Neutral, $69 - Buy, $37

    Prikaži ovu nit
    Poništi
  18. proslijedio/la je Tweet
    prije 6 sati
    Poništi
  19. proslijedio/la je Tweet
    prije 6 sati

    Dow jumps more than 400 points, S&P 500 closes at record as market shakes off coronavirus fears

    Poništi
  20. prije 6 sati

    . Pharmaceuticals Reports Fiscal 2020 First Quarter Results .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·